News
Chinese generic drug firms face stiff competition from Indian drugmakers
They offer lower labour costs and stronger R&D capabilities.
Chinese generic drug firms face stiff competition from Indian drugmakers
They offer lower labour costs and stronger R&D capabilities.
OUE Lippo Healthcare buys 70% stake in Wuxi Bohai Hospital for $1.9m
The Grade II hospital has 100 beds.
StartupCare and Generali launch digital platform for group health insurance
The app offers 24/7 pre-diagnosis and e-claim services.
StartupCare and Generali launch digital platform for group health insurance
The app offers 24/7 pre-diagnosis and e-claim services.
India pharma industry to hit over $38b by 2022
The government is urged to create a research ecosystem that will support the sector's growth.
GIC and investment firm KKR invest $940m in Philippine hospital group
The consortium will subscribe to $136.67m worth of 41.3 million new common shares.
Top five healthcare stocks in Singapore averaged total returns of 29.5% YTD
ISEC leads the pack at 48.6%.
Singapore, Philippines spearhead medtech across SEA
The Lion City’s Diagnostics Development hub has delivered 400 technologies and four products since 2014.
India e-health record market to grow at 5% CAGR to 2025
The implementation of UHC will fuel the shift to digital.
HC Surgical Specialist profits up 38% to $880,000 in Q1
New acquisitions from the previous financial year brought growth.
Japanese pharma sales take hit from 'opaque' pricing system
It will grow at a CAGR of 2.3% to $124b in 2023.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Top Chinese drug distributors grapple with tepid margins
Blame the two-invoice system.
Chinese pharmas face price pressures from Indian entrants under GPO
The entrance of Indian players may cut prices further by 30%.
APAC's employer medical benefit costs may rise 8.7% in 2020
This growth will be led by Malaysia and Thailand.
Resource Center
Read Here
Advertise
Sign Up
Event News
Only one of two leading firms achieves 80% of their digital transformation project targets.
